AT298692B - Verfahren zur Herstellung des neuen 9α-Fluor-16-fluormethylen-prednisolon-21-önanthats - Google Patents

Verfahren zur Herstellung des neuen 9α-Fluor-16-fluormethylen-prednisolon-21-önanthats

Info

Publication number
AT298692B
AT298692B AT120470A AT120470A AT298692B AT 298692 B AT298692 B AT 298692B AT 120470 A AT120470 A AT 120470A AT 120470 A AT120470 A AT 120470A AT 298692 B AT298692 B AT 298692B
Authority
AT
Austria
Prior art keywords
oenanthate
fluoromethylene
prednisolone
fluoro
preparation
Prior art date
Application number
AT120470A
Other languages
English (en)
Original Assignee
Merck Anlagen Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Anlagen Gmbh filed Critical Merck Anlagen Gmbh
Application granted granted Critical
Publication of AT298692B publication Critical patent/AT298692B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R4/00—Electrically-conductive connections between two or more conductive members in direct contact, i.e. touching one another; Means for effecting or maintaining such contact; Electrically-conductive connections having two or more spaced connecting locations for conductors and using contact members penetrating insulation
    • H01R4/02—Soldered or welded connections
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01R—ELECTRICALLY-CONDUCTIVE CONNECTIONS; STRUCTURAL ASSOCIATIONS OF A PLURALITY OF MUTUALLY-INSULATED ELECTRICAL CONNECTING ELEMENTS; COUPLING DEVICES; CURRENT COLLECTORS
    • H01R9/00—Structural associations of a plurality of mutually-insulated electrical connecting elements, e.g. terminal strips or terminal blocks; Terminals or binding posts mounted upon a base or in a case; Bases therefor
    • H01R9/22—Bases, e.g. strip, block, panel
    • H01R9/28—Terminal boards

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT120470A 1969-02-11 1970-02-10 Verfahren zur Herstellung des neuen 9α-Fluor-16-fluormethylen-prednisolon-21-önanthats AT298692B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1906586A DE1906586C3 (de) 1969-02-11 1969-02-11 9 alpha-Fluor-16-fluormethylenprednisolon-21-önanthat, Verfahren zu seiner Herstellung und diese enthaltende pharmazeutische Zubereitung

Publications (1)

Publication Number Publication Date
AT298692B true AT298692B (de) 1972-05-25

Family

ID=5724819

Family Applications (3)

Application Number Title Priority Date Filing Date
AT00126/71A AT303277B (de) 1969-02-11 1970-02-10 Verfahren zur herstellung von neuem 9 alpha-fluor-16-fluormethylenprednisolon-21-oenanthat
AT125/71A AT305503B (de) 1969-02-11 1970-02-10 Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat
AT120470A AT298692B (de) 1969-02-11 1970-02-10 Verfahren zur Herstellung des neuen 9α-Fluor-16-fluormethylen-prednisolon-21-önanthats

Family Applications Before (2)

Application Number Title Priority Date Filing Date
AT00126/71A AT303277B (de) 1969-02-11 1970-02-10 Verfahren zur herstellung von neuem 9 alpha-fluor-16-fluormethylenprednisolon-21-oenanthat
AT125/71A AT305503B (de) 1969-02-11 1970-02-10 Verfahren zur herstellung von neuem 9alpha-fluor-16-fluormethylen-prednisolon-21-oenanthat

Country Status (15)

Country Link
US (1) US3681409A (de)
AT (3) AT303277B (de)
BE (1) BE745708A (de)
BR (1) BR6915196D0 (de)
CH (1) CH534673A (de)
DE (1) DE1906586C3 (de)
DK (1) DK123475B (de)
ES (1) ES376409A1 (de)
FR (1) FR2034535B1 (de)
GB (1) GB1247641A (de)
HU (1) HU165223B (de)
IL (1) IL33812A (de)
NL (1) NL7001197A (de)
PL (1) PL80839B1 (de)
SE (1) SE356744B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU572589B2 (en) 1983-12-14 1988-05-12 Upjohn Company, The 11(alpha)-difluoromethyl and (e)-and (z)-11-fluoromethylene steroids
TW201914575A (zh) * 2017-09-19 2019-04-16 大江生醫股份有限公司 地龍蛋白用於製造調理皮膚醫藥組成物之用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH405306A (de) * 1959-02-10 1966-01-15 Ciba Geigy Verfahren zur Herstellung von Pregnadienverbindungen
DE1177151B (de) * 1961-06-08 1964-09-03 Merck Ag E Verfahren zur Herstellung von 16-Chlormethylen- bzw. 16-Brommethylen-steroiden

Also Published As

Publication number Publication date
AT303277B (de) 1972-10-15
DE1906586C3 (de) 1974-01-03
SE356744B (de) 1973-06-04
DK123475B (da) 1972-06-26
FR2034535A1 (de) 1970-12-11
US3681409A (en) 1972-08-01
CH534673A (de) 1973-03-15
BE745708A (de) 1970-08-10
DE1906586B2 (de) 1973-06-07
IL33812A0 (en) 1970-03-22
PL80839B1 (de) 1975-08-30
GB1247641A (en) 1971-09-29
NL7001197A (de) 1970-08-13
AT305503B (de) 1973-01-15
IL33812A (en) 1973-05-31
FR2034535B1 (de) 1973-01-12
BR6915196D0 (pt) 1973-02-13
DE1906586A1 (de) 1970-11-05
HU165223B (de) 1974-07-27
ES376409A1 (es) 1973-01-01

Similar Documents

Publication Publication Date Title
AT303055B (de) Verfahren zur Herstellung von neuen β-Aryl-2-aminoalkoxy-styrolen
AT298452B (de) Verfahren zur Herstellung von neuen Aminoalkylphenolen
AT317192B (de) Verfahren zur Herstellung von neuen Naphthylalkylaminen
AT297024B (de) Verfahren zur Herstellung des neuen Di-adenin-pyridoxal-phosphates
AT295547B (de) Verfahren zur Herstellung von neuen 4-Acyloxy-azetidin-2-onen
AT317249B (de) Verfahren zur Herstellung von neuen Dialkyl-xanthin-Derivaten
CH520706A (de) Verfahren zur Herstellung von neuen Bezothiazepinderivaten
AT303036B (de) Verfahren zur Herstellung von neuen Nitrofuryl-triazolo-pyrimidinen
AT301021B (de) Verfahren zur Herstellung des neuen Erythromycylamins
AT291450B (de) Verfahren zur Herstellung neuen 16α-Hydroxy-17α-aminosteroiden
AT303751B (de) Verfahren zur Herstellung von neuen Amidophenylguanidinen
AT294110B (de) Verfahren zur Herstellung von neuen 6-Alkoxy-pyridaziniumverbindungen
AT300196B (de) Verfahren zur Herstellung des neuen Erythromycyl-B-amins
CH529141A (de) Verfahren zur Herstellung von neuen 6-Hydrazino-Pyridazinen
AT293411B (de) Verfahren zur Herstellung von neuen 2-Alkyl-pyridazoniumverbindungen
CH540899A (de) Verfahren zur Herstellung von neuen Neriifolin-Derivaten
AT295759B (de) Verfahren zur Herstellung des neuen Nα-Acetyl-2-O-methyltyrosin-oxytocins
AT303713B (de) Verfahren zur Herstellung von neuen 1-Alkoxyanthrachinonen
AT296333B (de) Verfahren zur Herstellung von neuen 4-Oxaphosphorinanen
AT301053B (de) Verfahren zur Herstellung von neuen 14β-Hydroxy-15α-acyloxy-cardenoliden
AT299952B (de) Verfahren zur Herstellung von neuen substituierten 2-Azabicycloalkanen
AT298692B (de) Verfahren zur Herstellung des neuen 9α-Fluor-16-fluormethylen-prednisolon-21-önanthats
AT294842B (de) Verfahren zur Herstellung des Chinoxalin-di-N-oxyd-aldehyds
CH518943A (de) Verfahren zur Herstellung von neuen Derivaten des p-Aminoalkyl-benzolsulfonamids
AT300216B (de) Verfahren zur Herstellung von neuen d-18-Methyl-17α-alkinyl-4-östren-17β-olen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee